Simultaneous high-dose external irradiation and daily cisplatin in unresectable, non-metastatic adenocarcinoma of the pancreas: a phase I-II study

Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
T D NguyenM Ychou

Abstract

Clinical trials have demonstrated that high dose radiation therapy and daily cisplatin (CDDP) could increase local control and survival in carcinoma from various sites. The present phase I-II study has combined high dose radiation therapy and daily CDDP at escalating dosages. From August 1994 to December 1995, 23 patients with non-resectable carcinoma of the pancreas were enrolled in a phase I-II multicentric, pilot study to test the toxicity and the effectiveness of high dose radiotherapy and daily cisplatin (CDDP) at escalating dosages. A dose of 6 mg/sqm/day of CDDP was selected for the phase II step since no grade IV toxicity occurred in any patient in the phase I step. Toxicity was considered fairly acceptable. At the time of analysis, the 23 patients who entered the study had clear evidence of evolutive disease either locally or distantly in the liver. It is suggested that high dose radiotherapy (60 Gy continuously) and daily CDDP have little effect on local control of the tumor and survival, and only a moderate effect on pain. In unresectable, apparently non-metastatic cancers of the pancreas, there is an urgent need for new agents or new combinations of agents to be tested.

References

Jul 1, 1977·Cancer·S K Carter
Mar 1, 1978·Cancer·R R DobelbowerK A Strubler
Jan 1, 1990·Cancer Chemotherapy and Pharmacology·G MilanoJ L Lagrange
May 1, 1989·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·A C BeggH Bartelink
Jun 1, 1995·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·E Van Cutsem, J Fevery
Jun 1, 1994·The British Journal of Surgery·K R PalmerR C Leonard
Jan 1, 1993·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·J A WilsN Duez
Nov 1, 1995·Cancer·J E NiederhuberH R Menck
Aug 1, 1996·Annals of Oncology : Official Journal of the European Society for Medical Oncology·B GlimeliusC Svensson

❮ Previous
Next ❯

Citations

Apr 3, 2001·Cancer·T OkusakaUNKNOWN Non-surgical Treatment Group for Pancreatic Cancer in Japan
Jan 5, 2002·International Journal of Radiation Oncology, Biology, Physics·Erik W KorevaarAnders Brahme
Jan 10, 1998·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·M Kjaer
May 21, 2009·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Myriam BouchardChristopher H Crane
Dec 5, 2003·Alimentary Pharmacology & Therapeutics·S ShoreJ P Neoptolemos
Jul 10, 2012·International Journal of Radiation Oncology, Biology, Physics·Florence HuguetRoss A Abrams
Jul 19, 2013·The Journal of the Acoustical Society of America·Timothy W Leishman, Brian E Anderson
Apr 30, 2015·The Journal of the Acoustical Society of America·Eran Gonen, Gershon Grossman

❮ Previous
Next ❯

Related Concepts

Related Feeds

Carcinoma, Ductal

Ductal carcinoma is a malignant neoplasm involving the ductal systems of any of a number of organs, such as the mammary glands, pancreas, prostate or lacrimal gland. Discover the latest research on ductal carcinoma here.

© 2021 Meta ULC. All rights reserved